Rerose OM-20 is used to treat conditions caused by excessive stomach acid, such as gastroesophageal reflux disease (GERD), stomach and duodenal ulcers, and Zollinger-Ellison syndrome. It effectively relieves heartburn and acid regurgitation.
REROSE-OM 20 is a core gastrointestinal formulation from MK Healthcare, featuring Omeprazole (20mg) as its active pharmaceutical ingredient. Classified as a potent Proton Pump Inhibitor (PPI), REROSE-OM 20 is specifically engineered to address acid-peptic disorders by significantly reducing the volume of gastric acid produced in the stomach. This 20mg strength is the clinical gold standard for providing rapid and sustained relief from common symptoms such as heartburn, acid regurgitation, and persistent indigestion, helping patients regain their digestive comfort.The primary therapeutic application of REROSE-OM 20 lies in the effective management of Gastroesophageal Reflux Disease (GERD) and the healing of erosive esophagitis. By targeting the $H^+/K^+-ATPase$ enzyme system at the secretory surface of the gastric parietal cells, Omeprazole blocks the final step of acid secretion. This mechanism creates an ideal internal environment for the healing of gastric and duodenal ulcers, while simultaneously protecting the delicate esophageal lining from chronic acid damage and irritation.Beyond treating simple acidity, REROSE-OM 20 plays a critical role in preventing gastric ulcers often caused by the long-term use of Nonsteroidal Anti-inflammatory Drugs (NSAIDs). It is also a vital component of triple-therapy regimens aimed at eradicating H. pylori infections, a leading cause of recurring peptic ulcers. The "Once Daily" (OD) dosing schedule ensures high patient compliance, as a single morning dose provides a full 24 hours of acid suppression, allowing for a worry-free day and a comfortable night's sleep.As a signature product of MK Healthcare, an ISO-GMP certified manufacturer, REROSE-OM 20 is produced using advanced pharmaceutical technology to ensure consistent bioavailability and stability. For PCD Pharma Franchise partners and healthcare distributors, this capsule represents a high-demand cornerstone of the gastroenterology segment. To achieve the best clinical outcomes, it is recommended that REROSE-OM 20 be taken on an empty stomach, typically 30 minutes before breakfast, to maximize its ability to inhibit acid pumps before they are activated by food.